Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+15.42%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$52.9B
AUM Growth
+$52.9B
(+9.6%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
27.09%
Holding
978
New
135
Increased
353
Reduced
289
Closed
117
Top Buys
| 1 |
CSX Corp
CSX
|
$218M |
| 2 |
Merck
MRK
|
$195M |
| 3 |
HES
Hess
HES
|
$171M |
| 4 |
Walmart
WMT
|
$138M |
| 5 |
Lockheed Martin
LMT
|
$102M |
Top Sells
| 1 |
Canadian Pacific Kansas City
CP
|
$231M |
| 2 |
Amgen
AMGN
|
$159M |
| 3 |
Honeywell
HON
|
$124M |
| 4 |
Domino's
DPZ
|
$124M |
| 5 |
Dover
DOV
|
$118M |
Sector Composition
| 1 | Technology | 26.41% |
| 2 | Healthcare | 17.14% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Ventas
VTR
$30.7B
| $44.4M | 0.08% |
1,019,700
+53,800
| +6% | +$2.34M |
|
252
Pfizer
PFE
$141B
| $44.4M | 0.08% |
1,599,522
-2,403,667
| -60% | -$66.7M |
|
253
Centene
CNC
$14.5B
| $44.2M | 0.08% |
563,828
+181,964
| +48% | +$14.3M |
|
254
Revvity
RVTY
$10.1B
| $44.2M | 0.08% |
421,088
+201,200
| +92% | +$21.1M |
|
255
Realty Income
O
$52.9B
| $44.1M | 0.08% |
815,700
+112,500
| +16% | +$6.09M |
|
256
Ionis Pharmaceuticals
IONS
$9B
| $43.4M | 0.08% |
1,000,000
-385,300
| -28% | -$16.7M |
|
257
NewAmsterdam Pharma
NAMS
$2.75B
| $43.2M | 0.08% |
1,824,601
+524,601
| +40% | +$12.4M |
|
258
Ameriprise Financial
AMP
$48B
| $43.1M | 0.08% |
98,268
| – | – |
|
259
Hayward Holdings
HAYW
$3.4B
| $43M | 0.08% |
2,810,085
+19,010
| +0.7% | +$291K |
|
260
Monster Beverage
MNST
$60.8B
| $43M | 0.08% |
724,622
+52,100
| +8% | +$3.09M |
|
261
American Tower
AMT
$94.3B
| $42.9M | 0.08% |
217,205
-75,600
| -26% | -$14.9M |
|
262
Bank of New York Mellon
BK
$73.1B
| $42.9M | 0.08% |
744,816
-2,200
| -0.3% | -$127K |
|
263
Fortinet
FTNT
$58.2B
| $42.7M | 0.08% |
625,190
+6,100
| +1% | +$417K |
|
264
Microchip Technology
MCHP
$34B
| $42.5M | 0.08% |
474,000
+89,500
| +23% | +$8.03M |
|
265
American International
AIG
$44.7B
| $42.1M | 0.08% |
538,638
-628,300
| -54% | -$49.1M |
|
266
Liberty Broadband Class C
LBRDK
$8.68B
| $42M | 0.08% |
734,372
+50,000
| +7% | +$2.86M |
|
267
Spyre Therapeutics
SYRE
$1B
| $41.9M | 0.08% |
1,105,200
+105,200
| +11% | +$3.99M |
|
268
Humana
HUM
$37.4B
| $41.6M | 0.08% |
119,910
-21,797
| -15% | -$7.56M |
|
269
Prudential Financial
PRU
$37.5B
| $41.6M | 0.08% |
+354,051
| New | +$41.6M |
|
270
Roivant Sciences
ROIV
$8.39B
| $41.5M | 0.08% |
3,934,752
-1,340,248
| -25% | -$14.1M |
|
271
Savara
SVRA
$572M
| $41.3M | 0.08% |
8,287,930
+650,000
| +9% | +$3.24M |
|
272
Evolent Health
EVH
$1.09B
| $41.2M | 0.08% |
1,256,406
+335,039
| +36% | +$11M |
|
273
Axsome Therapeutics
AXSM
$6.13B
| $41.1M | 0.08% |
515,000
+150,000
| +41% | +$12M |
|
274
Allstate
ALL
$53.3B
| $41.1M | 0.08% |
237,519
-16,700
| -7% | -$2.89M |
|
275
Nkarta
NKTX
$149M
| $41.1M | 0.08% |
3,800,000
+350,000
| +10% | +$3.78M |
|